Company Overview

Company name: Canopy Growth (TSE: WEED)
Description: Manufacturer and distributor of cannabis based products. The company’s products are available in diverse brands and curated cannabis strain varieties in dried and oil extract forms, enabling the medical industries and other industries avail agricultural cannabis avail products to use to treat symptoms such as chronic pain, seizures, muscle spasms, nausea and loss of appetite.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.canopygrowth.com
Employees: 1,033
City: Smiths Falls
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 239.07
Business status: Profitable
Ownership: Publicly Held
Exchange: TSE
Ticker: WEED
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company (TSX: WEED) reached a definitive agreement to be acquired by Constellation Brands (NYSE: STZ) for CAD 5.8 billion on August 15, 2018.
Number of active investors:
Profile last updated: 03-Nov-2018
Last known valuation: 10,249.42
Last known valuation date: 15-Aug-2018